Pharmafile Logo
Pharmafocus logo
Advanced Search

China

Showing 15 posts of 254 posts found.

mask-1954673_1280

China’s viral pneumonia spreads to Japan

January 17, 2020
Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia

A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …

News
49391632522_2133e0262f_b

US-China trade deal sees changes on drug patents

January 16, 2020
Business Services China, Chinese Drug Patents, Trade Deal, US Drug Patents, US-China Trade Deal

The US and China signed the first part of a broader trade pact that included setting up a system to …

News
6934974672_fd18b2ea20_b

Chinese coronavirus found in Thailand

January 14, 2020
Manufacturing and Production China, WHO, World Health Organisation, Wuhan, pneumonia, thailand

The recent viral pneumonia outbreak in Wuhan China has spread to Thailand.The patient is a 61 year old woman who …

News
nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020
Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …

News
smog_descends_on_wuhan_hubei_china

Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out

January 6, 2020
Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia

A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …

News

AstraZeneca’s drug Lokelma approved in China

January 6, 2020
Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium

AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …

News
astrazeneca-sign

AstraZeneca’s triple combination therapy for patients with COPD approved in China

December 23, 2019
Sales and Marketing AstraZeneca, COPD, China, respiration

AstraZeneca has announced that budesonide-glycopyrroniunm-formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease …

News
34778112_496a002303_b

Drugmakers cut prices by 61% to get on Chinese reimbursement list

November 28, 2019
Manufacturing and Production AstraZeneca, China, China National Reimbursement Scheme, Novartis, Roche Holding

AstraZeneca and Roche Holding are among a number of drugmakers to cut their prices in order to get on China’s …

News
astrazeneca_plaque_42

AstraZeneca reveals three-pronged “large-scale” R&D initiatives in China

November 7, 2019
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China

AstraZeneca has doubled down on its commitment to the Chinese region with the announcement of three “large-scale initiatives” in the …

News
shutterstock_38078521

China green lights first novel Alzheimer’s therapy since 2003

November 4, 2019
Sales and Marketing Alzheimer's, China, Green Valley, Oligomannate, pharma

Shanghai Green Valley Pharmaceuticals has announced that its therapy Oligomannate (GV-971) has secured marketing approval from China’s National Medical Products Administration (NMPA) …

News
shutterstock_87495637

Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region

November 1, 2019
Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma

Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …

News
eisa0008_web

China approves Eisai’s Fycompa for partial onset epileptic seizures

October 16, 2019
Research and Development, Sales and Marketing China, Eisai, Fycompa, epilepsy, pharma

Tokyo-headquartered firm Eisai has announced that its antiepileptic drug (AED) Fycompa (perampanel) has received approval from China’s National Medical Products …

News
astrazeneca_plaque

AZ’s Tagrisso secures China approval in first-line advanced lung cancer

September 4, 2019
Research and Development, Sales and Marketing AstraZeneca, China, Tagrisso, lung cancer, pharma

AstraZeneca’s Tagrisso (osimertinib) has secured approval in China from the country’s National Medical Products Administration (NMPA) in the first-line treatment …

News
shutterstock_2

Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds

August 28, 2019
Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma

Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023